← Leaderboards
Sadhan Majumder
University Of Tx Md Anderson Can Ctr
$10,510,614
Attributed
$12,287,121
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,287,121 · 9
By mechanism
R01$10,311,977 · 6
R33$1,135,224 · 1
R61$823,920 · 1
R13$16,000 · 1
Top collaborators
- Hui-Lin Pan8 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Hui-Lin Pan$27,634,836
- Vidya Gopalakrishnan$1,524,947
- Michael J Overman$2,432,364
- Susan K Peterson$7,271,594
- Kanwal Raghav$992,074
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelMediatingGenesMedulloblastomaNeuronsBaseTherapeutic TargetBrain NeoplasmsVp 16Stem CellsTumorTumorigenesisPharmaceutical PreparationsMicrornasGenetic TranscriptionIn VivoOverexpressionAffectNeoplastic CellCancer Stem CellBiologyPathway InteractionsGender DifferencePublishing
Grant awards (40)
REST-mediated regulation of opioid receptors in chronic pain mouse models$567,612
R33 · FY2025 · DA · contact PI
New Therapeutic Approaches for Stratified High-REST GBM Subtype$364,500
R01 · FY2025 · NS · contact PI
REST-mediated regulation of opioid receptors in chronic pain mouse models$567,612
R33 · FY2024 · DA · contact PI
New Therapeutic Approaches for Stratified High-REST GBM Subtype$392,850
R01 · FY2024 · NS · contact PI
New Therapeutic Approaches for Stratified High-REST GBM Subtype$405,000
R01 · FY2023 · NS · contact PI
2023 Basic Mechanisms to Clinical Trials in Brain Tumors Gordon Research Conference$16,000
R13 · FY2023 · CA · contact PI
New Therapeutic Approaches for Stratified High-REST GBM Subtype$405,000
R01 · FY2022 · NS · contact PI
REST-mediated epigenomic and transcriptomic signatures in neuropathic pain$394,593
R01 · FY2022 · NS · contact PI
REST-mediated regulation of opioid receptors in chronic pain mouse models$411,960
R61 · FY2021 · DA · contact PI
New Therapeutic Approaches for Stratified High-REST GBM Subtype$405,000
R01 · FY2021 · NS · contact PI
REST-mediated epigenomic and transcriptomic signatures in neuropathic pain$397,378
R01 · FY2021 · NS · contact PI
REST-mediated regulation of opioid receptors in chronic pain mouse models$411,960
R61 · FY2020 · DA · contact PI
REST-mediated epigenomic and transcriptomic signatures in neuropathic pain$400,950
R01 · FY2020 · NS · contact PI
REST-mediated epigenomic and transcriptomic signatures in neuropathic pain$400,950
R01 · FY2019 · NS · contact PI
Implications of a novel glioblastoma classification defined by miR-21-Sox2 status$379,227
R01 · FY2015 · NS · contact PI
Implications of a novel glioblastoma classification defined by miR-21-Sox2 status$375,433
R01 · FY2014 · NS · contact PI
Implications of a novel glioblastoma classification defined by miR-21-Sox2 status$365,954
R01 · FY2013 · NS · contact PI
REST/NRSF-mediated medulloblastoma tumorigenesis$251,390
R01 · FY2013 · CA · contact PI
Implications of a novel glioblastoma classification defined by miR-21-Sox2 status$379,227
R01 · FY2012 · NS · contact PI
REST/NRSF-mediated medulloblastoma tumorigenesis$267,437
R01 · FY2012 · CA · contact PI
REST/NRSF-mediated medulloblastoma tumorigenesis$267,437
R01 · FY2011 · CA · contact PI
REST/NRSF-mediated medulloblastoma tumorigenesis$275,708
R01 · FY2010 · CA · contact PI
Novel Convergence of Medulloblastoma Mechanisms via REST$236,267
R01 · FY2010 · CA · contact PI
REST/NRSF-mediated medulloblastoma tumorigenesis$275,708
R01 · FY2009 · CA · contact PI
Novel Convergence of Medulloblastoma Mechanisms via REST$236,267
R01 · FY2009 · CA · contact PI
Novel Convergence of Medulloblastoma Mechanisms via REST$236,267
R01 · FY2008 · CA · contact PI
Novel Convergence of Medulloblastoma Mechanisms via REST$236,267
R01 · FY2007 · CA · contact PI
New Mechanisms of and Mouse Models for Medulloblastoma$262,464
R01 · FY2006 · CA · contact PI
Novel Convergence of Medulloblastoma Mechanisms via REST$243,323
R01 · FY2006 · CA · contact PI
New Mechanisms of and Mouse Models for Medulloblastoma$113,880
R01 · FY2006 · CA · contact PI
New Mechanisms of and Mouse Models for Medulloblastoma$268,780
R01 · FY2005 · CA
New Mechanisms of and Mouse Models for Medulloblastoma$111,000
R01 · FY2005 · CA
New Mechanisms of and Mouse Models for Medulloblastoma$268,780
R01 · FY2004 · CA
New Mechanisms of and Mouse Models for Medulloblastoma$268,780
R01 · FY2003 · CA
TRANSCRIPTION FACTOR REST/NRSF IN MEDULLOBLASTOMA$249,943
R01 · FY2003 · CA
New Mechanisms of and Mouse Models for Medulloblastoma$300,000
R01 · FY2002 · CA
TRANSCRIPTION FACTOR REST/NRSF IN MEDULLOBLASTOMA$242,663
R01 · FY2002 · CA
TRANSCRIPTION FACTOR REST/NRSF IN MEDULLOBLASTOMA$235,595
R01 · FY2001 · CA
TRANSCRIPTION FACTOR REST/NRSF IN MEDULLOBLASTOMA$228,733
R01 · FY2000 · CA
MECHANISM OF ENHANCER FUNCTION IN MOUSE EMBRYOS/OCCYTES$169,226
R01 · FY2000 · GM